BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 20133587)

  • 1. Aberrant overexpression and function of the miR-17-92 cluster in MLL-rearranged acute leukemia.
    Mi S; Li Z; Chen P; He C; Cao D; Elkahloun A; Lu J; Pelloso LA; Wunderlich M; Huang H; Luo RT; Sun M; He M; Neilly MB; Zeleznik-Le NJ; Thirman MJ; Mulloy JC; Liu PP; Rowley JD; Chen J
    Proc Natl Acad Sci U S A; 2010 Feb; 107(8):3710-5. PubMed ID: 20133587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemia.
    Jiang X; Huang H; Li Z; He C; Li Y; Chen P; Gurbuxani S; Arnovitz S; Hong GM; Price C; Ren H; Kunjamma RB; Neilly MB; Salat J; Wunderlich M; Slany RK; Zhang Y; Larson RA; Le Beau MM; Mulloy JC; Rowley JD; Chen J
    Proc Natl Acad Sci U S A; 2012 Nov; 109(47):19397-402. PubMed ID: 23132946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-9 is an essential oncogenic microRNA specifically overexpressed in mixed lineage leukemia-rearranged leukemia.
    Chen P; Price C; Li Z; Li Y; Cao D; Wiley A; He C; Gurbuxani S; Kunjamma RB; Huang H; Jiang X; Arnovitz S; Xu M; Hong GM; Elkahloun AG; Neilly MB; Wunderlich M; Larson RA; Le Beau MM; Mulloy JC; Liu PP; Rowley JD; Chen J
    Proc Natl Acad Sci U S A; 2013 Jul; 110(28):11511-6. PubMed ID: 23798388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemia.
    Schotte D; Lange-Turenhout EA; Stumpel DJ; Stam RW; Buijs-Gladdines JG; Meijerink JP; Pieters R; Den Boer ML
    Haematologica; 2010 Oct; 95(10):1675-82. PubMed ID: 20494936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of MLL-fusion/MYC⊣miR-26⊣TET1 signaling circuit in MLL-rearranged leukemia.
    Huang H; Jiang X; Wang J; Li Y; Song CX; Chen P; Li S; Gurbuxani S; Arnovitz S; Wang Y; Weng H; Neilly MB; He C; Li Z; Chen J
    Cancer Lett; 2016 Mar; 372(2):157-65. PubMed ID: 26791235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-106b~25 cluster is upregulated in relapsed MLL-rearranged pediatric acute myeloid leukemia.
    Verboon LJ; Obulkasim A; de Rooij JD; Katsman-Kuipers JE; Sonneveld E; Baruchel A; Trka J; Reinhardt D; Pieters R; Cloos J; Kaspers GJ; Klusmann JH; Zwaan CM; Fornerod M; van den Heuvel-Eibrink MM
    Oncotarget; 2016 Jul; 7(30):48412-48422. PubMed ID: 27351222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The miR-17-92 microRNA polycistron regulates MLL leukemia stem cell potential by modulating p21 expression.
    Wong P; Iwasaki M; Somervaille TC; Ficara F; Carico C; Arnold C; Chen CZ; Cleary ML
    Cancer Res; 2010 May; 70(9):3833-42. PubMed ID: 20406979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia.
    Li Z; Huang H; Chen P; He M; Li Y; Arnovitz S; Jiang X; He C; Hyjek E; Zhang J; Zhang Z; Elkahloun A; Cao D; Shen C; Wunderlich M; Wang Y; Neilly MB; Jin J; Wei M; Lu J; Valk PJM; Delwel R; Lowenberg B; Le Beau MM; Vardiman J; Mulloy JC; Zeleznik-Le NJ; Liu PP; Zhang J; Chen J
    Nat Commun; 2012 Feb; 3():688. PubMed ID: 22353710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-155 is upregulated in MLL-rearranged AML but its absence does not affect leukemia development.
    Schneider E; Staffas A; Röhner L; Krowiorz K; Heuser M; Döhner K; Bullinger L; Döhner H; Fogelstrand L; Rouhi A; Kuchenbauer F; Palmqvist L
    Exp Hematol; 2016 Dec; 44(12):1166-1171. PubMed ID: 27619068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-196b promotes cell proliferation and suppress cell differentiation in vitro.
    Cao D; Hu L; Lei D; Fang X; Zhang Z; Wang T; Lin M; Huang J; Yang H; Zhou X; Zhong L
    Biochem Biophys Res Commun; 2015 Jan; 457(1):1-6. PubMed ID: 25475721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consistent deregulation of gene expression between human and murine MLL rearrangement leukemias.
    Li Z; Luo RT; Mi S; Sun M; Chen P; Bao J; Neilly MB; Jayathilaka N; Johnson DS; Wang L; Lavau C; Zhang Y; Tseng C; Zhang X; Wang J; Yu J; Yang H; Wang SM; Rowley JD; Chen J; Thirman MJ
    Cancer Res; 2009 Feb; 69(3):1109-16. PubMed ID: 19155294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ZNF521 sustains the differentiation block in MLL-rearranged acute myeloid leukemia.
    Germano G; Morello G; Aveic S; Pinazza M; Minuzzo S; Frasson C; Persano L; Bonvini P; Viola G; Bresolin S; Tregnago C; Paganin M; Pigazzi M; Indraccolo S; Basso G
    Oncotarget; 2017 Apr; 8(16):26129-26141. PubMed ID: 28412727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The miR-17∼92 cluster contributes to MLL leukemia through the repression of MEIS1 competitor PKNOX1.
    Mian YA; Zeleznik-Le NJ
    Leuk Res; 2016 Jul; 46():51-60. PubMed ID: 27123834
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Liu J; Guo B; Chen Z; Wang N; Iacovino M; Cheng J; Roden C; Pan W; Khan S; Chen S; Kyba M; Fan R; Guo S; Lu J
    Blood; 2017 Mar; 129(11):1491-1502. PubMed ID: 28053194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization.
    Popovic R; Riesbeck LE; Velu CS; Chaubey A; Zhang J; Achille NJ; Erfurth FE; Eaton K; Lu J; Grimes HL; Chen J; Rowley JD; Zeleznik-Le NJ
    Blood; 2009 Apr; 113(14):3314-22. PubMed ID: 19188669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting epigenetic programs in MLL-rearranged leukemias.
    Bernt KM; Armstrong SA
    Hematology Am Soc Hematol Educ Program; 2011; 2011():354-60. PubMed ID: 22160057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct microRNA expression profiles in acute myeloid leukemia with common translocations.
    Li Z; Lu J; Sun M; Mi S; Zhang H; Luo RT; Chen P; Wang Y; Yan M; Qian Z; Neilly MB; Jin J; Zhang Y; Bohlander SK; Zhang DE; Larson RA; Le Beau MM; Thirman MJ; Golub TR; Rowley JD; Chen J
    Proc Natl Acad Sci U S A; 2008 Oct; 105(40):15535-40. PubMed ID: 18832181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypomethylation and expression of BEX2, IGSF4 and TIMP3 indicative of MLL translocations in acute myeloid leukemia.
    Röhrs S; Dirks WG; Meyer C; Marschalek R; Scherr M; Slany R; Wallace A; Drexler HG; Quentmeier H
    Mol Cancer; 2009 Oct; 8():86. PubMed ID: 19835597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant expression of miR-9/9* in myeloid progenitors inhibits neutrophil differentiation by post-transcriptional regulation of ERG.
    Nowek K; Sun SM; Bullinger L; Bindels EM; Exalto C; Dijkstra MK; van Lom K; Döhner H; Erkeland SJ; Löwenberg B; Jongen-Lavrencic M
    Leukemia; 2016 Jan; 30(1):229-37. PubMed ID: 26174629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.